Chronic Chagas disease (CCD) continues to be a major scourge for people living in South
America and an emergent medical problem outside the American Continent because of world
globalization. Chronic Chagas heart disease (CCHD) affects about 30% of patients with
CCD, appearing 20-30 years after infection with Trypanosoma
cruzi.[1] Prognosis of
CCDpatients is relentless, with a 5-year mortality approaching 35%.[2] CCHD patients have an outcome even
worse,[2] particularly those with
ventricular and atrial remodeling, which manifests by chronic systolic heart failure and
atrial fibrillation.[3,4]It is, therefore, important to recognize predictors of ventricular and atrial remodeling
in patients with CCHD to offer the proper available treatment for patients with this
condition. Systolic blood pressure, male sex, and New York Heart Association Functional
Class appear to predict ventricular remodeling in patients with CCD.[5] Conversely, as far as I know, predictors
of atrial remodeling have not yet been established for patients with this condition.In this issue of the Journal, Medeiros et al.[6] report on an original study of 135 Chagas diseasepatients (30% of
them in the indeterminate form and the remaining with CCHD) who have undergone overnight
polysomnography to assess the relationship of sleep-disordered breathing and cardiac
remodeling. Importantly, 62% of patients also had concomitant systemic arterial
hypertension (SAH). Moderate to severe obstructive sleep apnea (OSA) was found in 21% of
patients. Medeiros et al.[6] confirm that
male sex and SAH are predictors of ventricular remodeling, and also discovered that the
apnea-hypopnea index, a diagnostic marker of the severity of OAS, was a predictor of
both atrial and ventricular remodeling.The prevalence of OSA is 21% in a general population. It is moderate to severe in 9% of
affected individuals,[7] and increases
morbidity and mortality.[8] OSA has
independently been associated with SAH[9]
and with several different types of cardiovascular disorders, including chronic heart
failure,[10] a condition usually
associated with cardiac remodeling. It is noteworthy that OSA by itself has also been
independently associated with left ventricular remodeling and left atrial
diameter.[11]How can the exciting findings reported by Medeiros et al.[6] be incorporated in clinical practice? I think that it
would be necessary to test the usefulness of polysomnography in patients with CCD
without concomitant SAH. By doing that, we could rule out the additive effect of OSA and
SAH[11] on the genesis of
cardiac remodeling, as well as to establish the real effect of OSA on the induction of
cardiac abnormalities in patients with this condition.On the other hand, it is important to recognize that a substantial proportion of patients
with CCD do not have concomitant SAH in the study by Medeiros et al.[6] Therefore, it is reasonable to admit
that OSA by itself could have induced, at least in part, the atrial and ventricular
remodeling observed in that study. The appearance of OSA by itself might represent an
additional burden to myocardial function to patients with CCD/CCHD because OSA activates
sympathetic activity[12] and is
proinflammatory.[8]The histological findings observed in catecholaminecardiomyopathy are similar to those
found in CCHD,[13] thus suggesting a
role for autonomic dysfunction in the pathogenesis of this disease. Furthermore,
proinflammatory cytokines are more increased in patients with CCHD and SAH in comparison
with patients with CCHD alone,[14]
suggesting a role for cytokines in the pathogenesis of patients with this condition as
well. Clearly, the presence of OSA might represent a potential curable threat for
patients with CCHD.I congratulate Medeiros et al.[6] for this
important study, and I do hope that they continue to pursue this research line not only
because its potential contribution to the understanding of the pathogenesis of CCHD, but
also for its potential impact on the clinical course of this scourge to our people.
Authors: E Shahar; C W Whitney; S Redline; E T Lee; A B Newman; F J Nieto; G T O'Connor; L L Boland; J E Schwartz; J M Samet Journal: Am J Respir Crit Care Med Date: 2001-01 Impact factor: 21.405
Authors: R Espinosa; H A Carrasco; F Belandria; A M Fuenmayor; C Molina; R González; O Martínez Journal: Int J Cardiol Date: 1985-05 Impact factor: 4.164
Authors: Sandra de Araújo Costa; Salvador Rassi; Elis Marra da Madeira Freitas; Natália da Silva Gutierrez; Fabiana Miranda Boaventura; Larissa Pereira da Costa Sampaio; João Bastista Masson Silva Journal: Arq Bras Cardiol Date: 2017-03 Impact factor: 2.000
Authors: Savio Cardoso; Clerio Francisco de Azevedo Filho; Fábio Fernandes; Barbara Ianni; Jorge Andion Torreão; Mateus Diniz Marques; Luiz Francisco Rodrigues de Ávila; Raul Santos Filho; Charles Mady; Roberto Kalil-Filho; José Antônio Franchine Ramires; Marcio Sommer Bittencourt; Carlos E Rochitte Journal: Arq Bras Cardiol Date: 2020-12 Impact factor: 2.000